Tags: covid | vaccine | pfizer | biontech | fda | booster | omicron

Pfizer Applies for FDA Authorization of Omicron Booster in Kids Under 5

young boy getting a shot
(Dreamstime)

Monday, 05 December 2022 07:12 AM EST

Pfizer Inc and its German partner BioNTech SE said on Monday they have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization of their omicron-adapted COVID-19 vaccine booster for children aged 6 months through 4 years.

If authorized, children would receive the primary series consisting of two doses of the original Pfizer-BioNTech COVID vaccine and one shot of the omicron-adapted bivalent vaccine, the company said. The bivalent COVID-19 vaccine, which targets the original strain and the BA.4/BA.5 omicron subvariants, is currently authorized as a booster dose for ages 5 years and older in the United States and the European Union (EU). Last month, a real-world study of more than 360,000 people in the U.S. found the updated bivalent boosters, including those of rival Moderna Inc, offered increased protection against new coronavirus subvariants in people who have received up to four doses of the older vaccine. 

© 2025 Thomson/Reuters. All rights reserved.


Health-News
Pfizer Inc and its German partner BioNTech SE said on Monday they have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization of their omicron-adapted COVID-19 vaccine booster for children aged 6 months through 4 years....
covid, vaccine, pfizer, biontech, fda, booster, omicron, under 5
151
2022-12-05
Monday, 05 December 2022 07:12 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved